American Cannabis Operator Index Declines in December to End 2021 Down 34%

The American Cannabis Operator Index ended 2021 with its 10th consecutive decline, falling 6.8% to 44.75:

The Q4 decline of 23.4% followed a 22.8% loss in Q3. After gaining 45.7% in 2020, when it ended at 63.05, the index was down 33.9% in 2021:

The index, which launched at the end of October 2018 with a value of 100, reached a closing high of 124.16 a week later before declining to 70.64 in late December 2018. It then rallied as high as 119.53 in early April 2019 before selling off over the balance of the year and into March 2020. It has rebounded 187.7% from an all-time closing low on March 18, 2020 at 14.50:

During December, the index included 22 companies, including 17 multi-state operators (MSOs), two single-state operators (SSOs) and 3 focused solely on CBD extracted from industrial hemp. 6 companies posted gains, while 4 declined by more than 20% during the month, with a median return of -10.5%:

The four best performing stocks in December included Goodness Growth (CSE: GDNS) (OTC: GDNSF), MariMed (OTC: MRMD), Verano Holdings (CSE: VRNO) (OTC: VRNOF) and Ascend Wellness (CSE: AAWH.U) (OTC: AAWH) Ascend was one of the worst performing stocks in November.

The four worst performing stocks during the month included cbdMD (NYSE American: YCBD), Red White & Bloom (CSE: RWB) (OTC: RWBYF), Charlotte’s Web (TSX: CWEB) (OTC: CWBHF) and Planet 13 (CSE: PLTH) (OTC: PLNHF).

For January, the index will include 20 stocks following, with the deletions of Red White & Bloom and Unrivaled Brands (OTC: UNRV), both of which failed to meet the minimum of $200K average daily traded value.

In the next monthly review, we will summarize the performance for January and discuss any additions or deletions. Be sure to bookmark the page to stay current on American cannabis operators stock price movements within the day or from day-to-day.

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email